학술논문
Nanocarrier vaccines for SARS-CoV-2.
Document Type
Article
Author
Machhi, Jatin; Shahjin, Farah; Das, Srijanee; Patel, Milankumar; Abdelmoaty, Mai Mohamed; Cohen, Jacob D.; Singh, Preet Amol; Baldi, Ashish; Bajwa, Neha; Kumar, Raj; Vora, Lalit K.; Patel, Tapan A.; Oleynikov, Maxim D.; Soni, Dhruvkumar; Yeapuri, Pravin; Mukadam, Insiya; Chakraborty, Rajashree; Saksena, Caroline G.; Herskovitz, Jonathan; Hasan, Mahmudul
Source
Subject
*SARS-CoV-2
*ADULT respiratory distress syndrome
*COVID-19 pandemic
*VACCINES
*
*
*
Language
ISSN
0169-409X
Abstract
The SARS-CoV-2 global pandemic has seen rapid spread, disease morbidities and death associated with substantive social, economic and societal impacts. Treatments rely on re-purposed antivirals and immune modulatory agents focusing on attenuating the acute respiratory distress syndrome. No curative therapies exist. Vaccines remain the best hope for disease control and the principal global effort to end the pandemic. Herein, we summarize those developments with a focus on the role played by nanocarrier delivery. [Display omitted] [ABSTRACT FROM AUTHOR]